Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

GSK faces fine over Argentina clinical trial

January 6, 2012 Research and Development, Sales and Marketing Argentina, GSK, Vaccine, deaths, emerging markets

A court in Argentina says GSK should be fined for irregularities in recruitment during a trial in which children died. …
News

Biogen inks $299m deal for rare genetic disorder drug

January 5, 2012 Research and Development, Sales and Marketing Biogen, Isis Pharma

Biogen has signed a new deal with drug discovery firm Isis for its spinal muscular atrophy drug ISIS-SMNRx. Biogen will pay …
News

AstraZeneca to take Alzheimer’s drug into phase II

January 5, 2012 Research and Development Alzheimer's, AstraZeneca, Targacept

AstraZeneca is to continue the development of Targacept’s AZD1446 as a treatment for Alzheimer’s disease.AZD1446 is a selective modulator of …
News

Orphan status for haemophilia gene therapy

January 4, 2012 Research and Development AMT, gene therapy, haemophilia

Amsterdam Molecular Therapeutics has been granted an orphan drug designation for its gene therapy for haemophilia B.The FDA’s orphan designation …
News

Missing trial data ‘threatens integrity of medicine’

January 4, 2012 Research and Development, Sales and Marketing BMJ, clincial trial data, disclosure

Missing clinical trial data can harm patients and lead to needless costs for health systems, according to new research. A …
News

FDA accepts Pfizer’s arthritis pill for review

December 22, 2011 Research and Development, Sales and Marketing FDA, Pfizer, tofacitinib

The FDA has accepted Pfizer’s novel arthritis pill tofacitinib for review, and could be on the US market next year. …
News

AstraZeneca, Novo and Enlight sign collaborative research deal

December 20, 2011 Research and Development, Sales and Marketing AstraZeneca, Enlight, Novo Nordisk

AstraZeneca and Novo Nordisk have linked up with a US biosciences firm in a bid to enhance their R&D operations. …
News

AstraZeneca posts drug failures, takes $382m hit

December 20, 2011 Research and Development, Sales and Marketing AstraZeneca, depression, ovarian cancer

AstraZeneca has taken a major blow to its late stage pipeline, with one of its key cancer drugs now being …
News
Gilenya picture

Key product launches of 2011

December 19, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Actos, Benlysta, Brilique, Eliquis, Eylea, Incivek, Jevtana, Multaq, Victrelis, Xalkori, Yervoy, Zytiga, avastin, gilenya, key products

 Avastin 2011 saw a handful of high profile drugs suffer because of new safety and efficacy concerns. Chief among these …
Feature

Vertex chief to step down; names Jeffrey Leiden as new leader

December 19, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Vertex

Vertex has named a new chief executive to succeed Matthew Emmens, who will retire early next year. He will be …
Appointment

Amgen’s chief executive and chairman Kevin Sharer to retire

December 16, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen

Kevin Sharer, Amgen’s chairman and chief executive, has announced his retirement next year, leading the way for Robert Bradway to …
Appointment
Victrelis picture

Merck and Roche begin combination hep C trial

December 16, 2011 Research and Development, Sales and Marketing Copegus, Merck, Pegasys, Roche, Victrelis

Merck and Roche have started clinical trials to investigate combinations of their hepatitis C drugs. The first trial is designed …
News

Roche makes changes in its corporate executive committee

December 15, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Roche

Roche has made two new appointments in its corporate executive committee. Sophie Kornowski-Bonnet, currently general manager of Roche in France, …
Appointment
k_frazier_landscape_web

Frazier defends R&D investment and attacks price pressure

December 14, 2011 Research and Development, Sales and Marketing Merck, R&D productivity, prices

Merck & Co chief executive Kenneth Frazier has expressed concern that European governments increasingly want to pay unrealistically low prices …
News
ianreadweb

Ian Read elected as chairman of the board at Pfizer

December 13, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Kindler, Pfizer

Pfizer’s chief executive and president Ian Read has been elected as the firm’s new chairman. Read succeeds George Lorch as …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025